BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,394 | -34.9% | 2,158,000 | -47.4% | 0.14% | -31.3% |
| Q2 2023 | $3,192,387 | -34.7% | 4,100,000 | -37.9% | 0.20% | -38.7% |
| Q1 2023 | $4,887,815 | +2030.3% | 6,600,000 | +1220.0% | 0.32% | +2384.6% |
| Q4 2022 | $229,440 | -72.7% | 500,000 | -66.7% | 0.01% | -67.5% |
| Q3 2022 | $841,000 | +2.7% | 1,500,000 | 0.0% | 0.04% | +21.2% |
| Q2 2022 | $819,000 | -31.2% | 1,500,000 | -25.0% | 0.03% | -23.3% |
| Q1 2022 | $1,191,000 | -59.8% | 2,000,000 | -50.0% | 0.04% | -59.0% |
| Q4 2021 | $2,963,000 | -14.1% | 4,000,000 | +60.0% | 0.10% | -28.6% |
| Q3 2021 | $3,448,000 | +17.1% | 2,500,000 | +39.2% | 0.15% | +20.5% |
| Q2 2021 | $2,944,000 | – | 1,796,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aequim Alternative Investments LP | 34,000,000 | $55,930,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,241,000 | 2.33% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $81,551,000 | 2.26% |
| TFG Asset Management GP Ltd | 15,000,000 | $24,767,000 | 1.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 72,696,000 | $119,378,000 | 0.91% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $10,667,000 | 0.60% |
| Soleus Capital Management, L.P. | 1,950,000 | $3,201,000 | 0.49% |
| Context Capital Management, LLC | 2,000 | $3,290,000 | 0.30% |
| AVIVA PLC | 35,000,000 | $57,050,000 | 0.25% |
| MACKAY SHIELDS LLC | 14,611,000 | $24,035,000 | 0.23% |